Platinum-sensitive Recurrent Serous Ovarian Cancer
1 clinical trials · Condition
◉ Watch Platinum-sensitive Recurrent Serous Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| OSCA - Olaparib Standard of CAre Study (NCT02262273) | AstraZeneca | 2014-10-01 |
Track Platinum-sensitive Recurrent Serous Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.